Prevalence of human immunodeficiency virus infection and drug use in pregnant women: A critical review of the literature

Journal of Women's Health

Volumn 6, Issue 2, 1997, Pages 163-187

  Abercrombie, Priscilla D ^a,c   Booth, Karen M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ABUSE; FEMALE; GENDER; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RACE; REVIEW; SCREENING; SEROPREVALENCE; SOCIAL STATUS;

EID: 0030998355     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1997.6.163     Document Type: Review

References (108)

1. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy associated virus and acquired immunodeficiency syndrome. MMWR 1985;34:721.
2. Update: AIDS among women-United States, 1994. CDC Surveillance Summary. MMWR 1995;44:81.
3. Johnstone FD, MacCallum L, Brettle R, Inglis JM, Peutherer JF. Does infection with HIV affect the outcome of pregnancy? Br Med J [Clin Res Ed] 1988; 296:467.
4. Kurth A. Reproductive issues, pregnancy, and childbearing in HIV-infected women. In: Cohen FL, Durham JP, eds. Women, children and HIV/AIDS. New York: Springer, 1993;104.
5. Hutton N. Health prospects for children born to HIV-infected women. In: Faden RR, Kass NE, eds. HIV, AIDS and childbearing: Public policy, private lives. New York: Oxford University Press, 1996:63.
6. Frenkel LD, Gaur S. Perinatal HIV infection and AIDS. Clin Perinatol 1994;21:95.
7. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 1995;44 (RR-7):1.
8. European Collaborative Study. Children born to women with HIV-1 infection: Natural history and risk of transmission. Lancet 1991;337:253.
9. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet 1988;2:1043.
10. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173.
11. Kuhn L, Stein ZA. Mother-to-infant HIV transmission: Timing, risk factors and prevention. Paediatr Perinat Epidemiol 1995;9:1.
12. Sobo EJ. Choosing unsafe sex: AIDS-risk denial among disadvantaged women. Philadelphia: University of Pennsylvania Press, 1995.
13. Lindsay MK, Peterson HB, Taylor EB, Blunt M, Willis S, Klein L. Routine human immunodeficiency virus infection screening of women requesting induced first-trimester abortion in an inner-city population. Obstet Gynecol 1990;76:347.
14. Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med 1988;318:525.
15. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA 1991;265:1704.
16. Pappaioanou M, George JR, Hannon WH, et al. HIV seroprevalence surveys of childbearing women-objectives, methods, and uses of the data. Public Health Rep 1990;105:147.
17. Pappaioanou M, Kashamuka M, Behets F, et al. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper. AIDS 1993;7:483.
18. Schoenbaum EE, Alderman MH. Antibody to the human immunodeficiency virus in women seeking abortion in New York City [letter]. Ann Intern Med 1987;107:599.
19. Little BB, Snell LM, Wendel GD, Gilstrap LC, Johnston WL, Gluck KL. HIV prevalence in pregnant intravenous drug users in Dallas, Texas. Tex Med 1991;87:81.
20. Barbacci MB, Dalabetta GA, Repke JT, et al. Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: Ineffectiveness of targeted screening. Sex Trans Dis 1990;17:122.
21. Lindsay MK, Johnson N, Peterson HB, Willis S, Williams H, Klein L. Human immunodeficiency virus infection among inner-city adolescent parturients undergoing routine voluntary screening, July 1987 to March 1991. Am J Obstet Gynecol 1992; 167:1096.
22. Lindsay MK, Peterson HB, Boring J, Gramling J, Willis S, Klein L. Crack cocaine: A risk factor for human immunodeficiency virus infection type 1 among inner-city parturients. Obstet Gynecol 1992;80:981.
23. Krasinski K, Borkowsky W, Bebenroth D, Moore T. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population [letter]. N Engl J Med 1988;318:185.
24. Hoxie NJ, Vergeront JM, Pfister JR, Hoffman G, Markwardt PA, Davis JP. HIV-1 among childbearing women and newborns in Wisconsin. Wis Med J 1990;89:627.
25. Salomon H, Belmonte A, Nguyen K, Gu Z, Gelfand M, Wainberg MA. Comparison of cord blood and peripheral blood mononuclear cells as targets for viral isolation and drug sensitivity studies involving human immunodeficiency virus type 1. J Clin Microbiol 1994;32:2000.
26. Andiman WA. Virologic and serologic aspects of human immunodeficiency virus infection in infants and children. Semin Perinatol 1989;13:16.
27. Sison AV, Campos JM. Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants. Clin Microbiol Rev 1992;5: 238.
28. Cassol SA, Lapointe N, Salas T, et al. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr 1992;5:113.
29. Kline MW, Lewis DE, Hollinger FB, et al. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 1994;13:90.
30. McIntosh K, Comeau AM, Wara D, et al. The utility of IgA antibody to human immunodeficiency virus type 1 in early diagnosis of vertically transmitted infection. Arch Pediatr Adolesc Med 1996;150:598.
31. Horowitz GM, Scott RT, Hankins GD. Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. J Reprod Med 1991;36:773.
32. Getchell J, Hausler WJ Jr, Ramirez M. HIV infection in childbearing women. Iowa Med 1991;81:386.
33. Rosenberg PS, Levy ME, Brundage JF, et al. Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA 1992;268(4):495.
34. Landesman S, Minkoff H, Holman S, McCalla S, Sijin O. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA 1987;258:2701.
35. Nicholas SW, Bateman DA, Ng SK, Dedyo T, Heagarty MC. Maternal-newborn human immunodeficiency virus infection in Harlem. Arch Pediatr Adolesc Med 1994;148:813.
36. Lindsay MK, Peterson HB, Feng TI, Slade BA, Willis S, Klein L. Routine antepartum human immunodeficiency virus infection screening in an inner-city population. Obstet Gynecol 1989;74:289.
37. Kaunitz AM, Brewer JL, Paryani SG, deSausure L, Sanchez-Ramos L, Harrington P. Prenatal care and HIV screening [letter]. JAMA 1987;258:2693.
38. McKay JG, Wykoff RF, Dowda H, Marshall TA. Human immunodeficiency virus: Seroprevalence in parturients in rural South Carolina. South Med J 1990;83:631.
39. Ellerbrock TV, Lieb S, Harrington PE, et al. Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med 1992;327:1704.
40. Novick LF, Berns D, Stricof R, Stevens R, Pass K, Wethers J. HIV seroprevalence in newborns in New York State. JAMA 1989;261:1745.
41. Hill DA, Thomas JC, Frenkel LM, Settlage RH, Lee M, Yonekura ML. Human immunodeficiency virus-1 seroprevalence among parturients in Los Angeles County public hospitals. Obstet Gynecol 1992;79:657.
42. Capell FJ, Vugia DJ, Mordaunt VL, et al. Distribu tion of HIV type 1 infection in childbearing women in California. Am J Public Health 1992;82:254.
43. Cozen W, Mascola L, Enguidanos R, et al. Screening for HIV and hepatitis B virus in Los Angeles County prenatal clinics: A demonstration project. J Acquir Immune Defic Syndr 1993;6:95.
44. Repke JT, Townsend TR, Coberly JS, McQuillan GM, Halsey NA, Quinn TC. Seroprevalence of human immunodeficiency virus type 1 among pregnant women. Am J Perinatol 1992;9:293.
45. Wasserheit JN. Epidemiological synergy: Interrelationships between HIV infection and other STDs. In: Chen LC, Amor JS, Segal SJ, eds. AIDS and women's reproductive health. New York: Plenum Press, 1991.
46. Plourde PJ, Pepin J, Agoki E, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994;170:313.
47. Figueroa JP, Brathwaite A, Morris J, et al. Rising HIV-1 prevalence among sexually transmitted disease clinic attenders in Jamaica: Traumatic sex and genital ulcers as risk factors. J Acquir Immune Defic Syndr 1994;7:310.
48. Plourde PJ, Plummer FA, Pepin J, et al. Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya. J Infect Dis 1992;166:86.
49. Weir SS, Feldblum PJ, Roddy RE, Zekeng L. Gonorrhea as a risk factor for HIV acquisition. AIDS 1994;8:1605.
50. National Institute on Drug Abuse, Department of Health and Human Services. Women and drug abuse. NIH Publication No. 94-3732, 1994.
51. Barton S, Harringan R, Tse A. Prenatal cocaine exposure: Implications for practice, policy development, and needs for future research. Perinatol 1995; 15:10.
52. Chasnoff I. Cocaine and pregnancy: Clinical and methodologic issues. Clin Perinatol 1991;18:113.
53. Day N, Richardson G. Prenatal marijuana use: Epidemiology, methodologic issues, and infant outcome. Clin Perinatol 1991;18:77.
54. Pelham T, Dejong A. Nationwide practices for screening and reporting prenatal cocaine abuse: A survey of teaching programs. Child Abuse Negl 1992;16:763.
55. Birchfield M, Scully J, Handler A. Perinatal screening for illicit drugs: Policies in hospitals in a large metropolitan area. J Perinatol 1995;15:208.
56. Poland M, Dombrowski M, Ager J, Sokol R. Punishing pregnant drug users: Enhancing the flight from care. Drug Alcohol Depend 1993;31:199.
57. Osterloh JD, Lee BL. Urine drug screening in mothers and newborns. Am J Dis Child 1989;143:791.
58. Hansen R, Evans A, Gillogley K, Hughes C, Krener P. Perinatal toxicology screening. J Perinatol 1992; 12:220.
59. Hawthorne J, Maier R. Drug abuse in an obstetric population of a midsized city. South Med J 1993; 86:1334.
60. Schulman M, Morel M, Karmen A, Chazotte C. Perinatal screening for drugs of abuse: Reassessment of current practice in a high-risk area. Am J Perinatol 1993;10:374.
61. MacKenzie RG, Cheng M, Haftel AJ. The clinical utility and evaluation of drug screening techniques. Pediatr Clin North Am 1987;34:423.
62. Ostrea EM Jr. Detection of prenatal drug exposure in the pregnant woman and her newborn infant. NIDA Res Monogr 1992;117:61.
63. Ostrea EM Jr, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 1992;89:107.
64. Moser JM, Jones VH, Kuthy ML. Use of cocaine during the immediate prepartum period by childbearing women in Ohio. Am J Prev Med 1993;9:85.
65. Bibb K, Stewart D, Walker J, Cook V, Wagener R. Drug screening in newborns and mothers using meconium samples, paired urine samples and interviews. J Perinatol 1995;15:199.
66. Neerhof M, MacGregor S, Retzky S, Sullivan T. Cocaine abuse during pregnancy: Peripartum prevalence and perinatal outcome. Am J Obstet Gynecol 1989;161:633.
67. Ryan R, Wagner C, Schultz J, et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr 1994;125:435.
68. George S, Price J, Hauth J, Barnette D, Preston P. Drug abuse screening of childbearing-age women in Alabama public health clinics. Am J Obstet Gynecol 1991;165:924.
69. Pegues D, Engelgau M, Woernle C. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics. Public Health Rep 1994;109:530.
70. Vaughn A, Carzoli R, Sanchez-Ramos L, Murphy S, Khan N, Chiu T. Community-wide estimation of illicit drug use in delivering women: Prevalence, demographics, and associated risk factors. Obstet Gynecol 1993;82:92.
71. Chasnoff I, Landress H, Barrett M. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990;322:1202.
72. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
73. Rubin J, Ferencz C, Loffredo C, Baltimore-Washington Infant Study Group. Use of prescription and nonprescription drugs in pregnancy. J Clin Epidemiol 1993;46:581.
74. Banks TL. Legal challenges: State intervention, reproduction, and HIV-infected women. In: Faden RR, Kass NE, eds. HIV, AIDS and childbearing. New York: Oxford University Press, 1996;143.
75. Schneider BE, Stoller N. Introduction: Feminist strategies of empowerment. In: Schneider BE, Stoller N, eds. Women resisting AIDS: Feminist strategies of empowerment. Philadelphia: Temple University Press, 1995.
76. Finkelstein N. Treatment programming for alcohol and drug-dependent pregnant women. Int J Addict 1993;28:1275.
77. Sperling RS, Sacks HS, Mayer L, Joyner M, Berkowitz RL. Umbilical cord blood serosurvey for human immunodeficiency virus in parturient women in a voluntary hospital in New York City. Obstet Gynecol 1989;73:179.
78. Wenstrom KD, Zuidema LJ. Determination of the seroprevalence of human immunodeficiency virus infection in gravidas by non-anonymous versus anonymous testing. Obstet Gynecol 1989;74:558.
79. Matuszak DL, Panny SR, Patel J, Israel E. HIV antibody seroprevalence among childbearing women surveyed in Maryland. Public Health Rep 1990; 105:562.
80. Checko PJ, Abshire JP, Roach AI, Markowski M, Backman L. HIV seroprevalence among childbearing women in Connecticut. Conn Med 1991;55:9.
81. Lindsay MK, Feng TI, Peterson HB, Slade BA, Willis S, Klein L. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol 1991;77:599.
82. Lindsay MK, Peterson HB, Willis S, et al. Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990. Am J Obstet Gynecol 1991;165:961.
83. Rosenfeld JA. Prenatal detection of HIV seropositivity in an urban practice. J Fam Pract 1991;32:214.
84. Donegan SP, Steger KA, Recla L, et al. Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: Implications for public health and obstetric practice. Am J Obstet Gynecol 1992;167:622.
85. Hsu HW, Moye J Jr, Kunches L, et al. Perinatally acquired human immunodeficiency virus infection: Extent of clinical recognition in a population-based cohort. Pediatr Infect Dis J 1992;11:941.
86. Lewis R, O'Brien JM, Ray DT, Sibai BM. The impact of initiating a human immunodeficiency ,virus screening program in an urban obstetric population. Am J Obstet Gynecol 1995;173:1329.
87. Frank D, Zuckerman B, Amaro H, et al. Cocaine use during pregnancy: Prevalence and correlates. Pediatrics 1988;82:888.
88. Gillogley K, Evans A, Hansen R, Samuels S, Batra K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990;163:1535.
89. Matera C, Warren W, Moomjy M, Fink D, Fox H. Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 1990; 163:797.
90. State prevalence of illicit drug use by pregnant women-Rhode Island. MMWR 1990;39:225.
91. Lurio J, Selwyn P. Underdetection of substance abuse. N Engl J Med 1991;325:1045.
92. McCalla S, Minkoff H, Feldman J, et al. The biologic and social consequences of perinatal cocaine use in an inner-city population: Results of an anonymous cross-sectional study. Am J Obstet Gynecol 1991;164:625.
93. Polzin W, Kopelman J, Brady K, Read J. Screening for illicit drug use in a military obstetric population. Obstet Gynecol 1991;78:600.
94. Schutzman D, Frankenfield-Chernicoff M, Clatterbaugh H, Singer J. Incidence of intrauterine cocaine exposure in a suburban setting. Pediatrics 1991;88:825.
95. Broekhuizen F, Utrie J, Van Mullem C. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol 1992; 166:1747.
96. Kokotailo P, Adger H, Duggan A, Repke J, Joffe A. Cigarette, alcohol, and other drug use by school-age pregnant adolescents: Prevalence, detection, and associated risk factors. Pediatrics 1992;90:328.
97. McCalla S, Minkoff H, Feldman J, Glass L, Valencia G. Predictors of cocaine use in pregnancy. Obstet Gynecol 1992;79:641.
98. O'Campo P, de Boer MA, Faden RR, Gielen AC, Kass N, Chiasson R. Discrepancies between women's personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases, and HIV infection. Med Care 1992;30:965.
99. Sloan L, Gay J, Snyder S, Bales W. Substance abuse during pregnancy in a rural population. Obstet Gynecol 1992;79:245.
100. Buchi K, Varner M, Chase R. The prevalence of substance abuse among pregnant women in Utah. Obstet Gynecol 1993;81:239.
101. Burke M, Roth D. Anonymous cocaine screening in a private obstetric population. Obstet Gynecol 1993; 81:354.
102. Castro L, Azen C, Hobel C, Platt L. Maternal tobacco use and substance abuse: Reported prevalence rates and associations with the delivery of small for gestational age neonates. Obstet Gynecol 1993;81:396.
103. Matti LK, Caspersen VM. Prevalence of drug use among pregnant women in a rural area. J Obstet Gynecol Neonatal Nurs 1993;22:510.
104. Rosengren S, Longobucco D, Bernstein B, et al. Meconium testing for cocaine metabolite: Prevalence, perceptions, and pitfalls. Am J Obstet Gynecol 1993; 168:1449.
105. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993;329:850.
106. Weathers WT, Crane MM, Sauvain KJ, Blackhurst DW. Cocaine use in women from a defined population: Prevalence at delivery and effects on growth in infants. Pediatrics 1993;91:350.
107. Yawn BP, Thompson LR, Lupo VR, Googins MK, Yawn RA. Prenatal drug use in Minneapolis-St. Paul, Minn.: A 4-year trend. Arch Fam Med 1994;3:520.
108. Weeman J, Zanetos M, DeVoe S. Intensive surveillance for cocaine use in obstetric patients. Am J Drug Alcohol Abuse 1995;21:233.